Allergan has reported a total net revenue of $3.6 billion in its continuing operations performance for the first quarter of 2017.
Global pharmaceutical company Allergan has announced that it will acquire US-based biotechnology company Bonti.
Global pharmaceutical company Allergan has announced key future growth drivers for its medical aesthetics portfolio at its first ever Medical Aesthetics Analyst Day this month.
Interest in medial aesthetics is at an all-time high according to a new report by global pharmaceutical company Allergan, which questioned individuals about their perceptions of beauty.
Global pharmaceutical company Allergan is set to purchase medical and cooling technology company ZELTIQ Aesthetics for US $56.50 per share.
Pharmaceutical company Allergan has completed its acquisition of regenerative medicine company LifeCell.
American biopharmaceutical company AbbVie has agreed to buy global pharmaceutical company Allergan in a $63 billion cash and stock deal.
Tessa Hilado, executive vice president and chief financial officer has retired from her post at global pharmaceutical company Allergan.
Global pharmaceutical company Allergan has announced it will purchase clinical-stage biotechnology company Vitae Pharmaceuticals.
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.